| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.818 | 0.004 | 0.818 | Vasodilator, coronary | 0.689 0.005 DBMET01269 | ||
| 0.718 | 0.005 | 0.768 | Vasodilator, peripheral | 0.768 0.004 DBMET01269 | DBMET01269 | |
| 0.693 | 0.004 | 0.693 | Diuretic | 0.658 0.004 DBMET01269 | ||
| 0.651 | 0.009 | 0.651 | Spasmolytic | 0.499 0.023 DBMET01269 | ||
| 0.64 | 0.012 | 0.64 | Antithrombotic | 0.622 0.014 DBMET01269 | ||
| 0.549 | 0.008 | 0.571 | Psychostimulant | 0.571 0.007 DBMET01269 | DBMET01269 | |
| 0.513 | 0.002 | 0.593 | Angiotensin-converting enzyme inhibitor | 0.593 0.002 DBMET01269 | DBMET01269 | |
| 0.509 | 0.011 | 0.509 | Vasodilator | 0.493 0.013 DBMET01269 | ||
| 0.52 | 0.027 | 0.52 | Immunostimulant | 0.507 0.028 DBMET01269 | ||
| 0.496 | 0.03 | 0.496 | Histamine release inhibitor | 0.436 0.057 DBMET01269 | ||
| 0.446 | 0.013 | 0.486 | Interleukin agonist | 0.486 0.01 DBMET01269 | DBMET01269 | |
| 0.441 | 0.012 | 0.441 | Thiol protease inhibitor | 0.384 0.014 DBMET01269 | ||
| 0.421 | 0.005 | 0.442 | Neurotrophic factor | 0.442 0.004 DBMET01269 | DBMET01269 | |
| 0.46 | 0.047 | 0.46 | 5 Hydroxytryptamine release inhibitor | 0.323 0.141 DBMET01269 | ||
| 0.42 | 0.025 | 0.42 | Cardiotonic | 0.411 0.027 DBMET01269 | ||
| 0.436 | 0.058 | 0.436 | Calcium channel L-type activator | 0.4 0.081 DBMET01269 | ||
| 0.388 | 0.012 | 0.445 | Thrombolytic | 0.445 0.008 DBMET01269 | DBMET01269 | |
| 0.394 | 0.023 | 0.397 | Insulysin inhibitor | 0.397 0.023 DBMET01269 | DBMET01269 | |
| 0.354 | 0.006 | 0.432 | Aminopeptidase B inhibitor | 0.432 0.004 DBMET01269 | DBMET01269 | |
| 0.374 | 0.033 | 0.414 | Platelet antagonist | 0.414 0.024 DBMET01269 | DBMET01269 | |
| 0.358 | 0.02 | 0.41 | Anticoagulant | 0.41 0.015 DBMET01269 | DBMET01269 | |
| 0.339 | 0.036 | 0.364 | Angiogenesis stimulant | 0.364 0.029 DBMET01269 | DBMET01269 | |
| 0.343 | 0.049 | 0.412 | Interleukin 2 agonist | 0.412 0.024 DBMET01269 | DBMET01269 | |
| 0.318 | 0.025 | 0.344 | Tyrosine 3 hydroxylase inhibitor | 0.344 0.017 DBMET01269 | DBMET01269 | |
| 0.299 | 0.014 | 0.326 | Neurotensin receptor agonist | 0.326 0.011 DBMET01269 | DBMET01269 | |
| 0.38 | 0.102 | 0.41 | Cyclophilin D inhibitor | 0.41 0.085 DBMET01269 | DBMET01269 | |
| 0.333 | 0.072 | 0.333 | Cholesterol antagonist | 0.257 0.12 DBMET01269 | ||
| 0.288 | 0.042 | 0.333 | Gastrin inhibitor | 0.333 0.016 DBMET01269 | DBMET01269 | |
| 0.248 | 0.004 | 0.248 | Leukocyte elastase inhibitor | 0.17 0.005 DBMET01269 | ||
| 0.291 | 0.056 | 0.291 | Hypoglycemic | 0.258 0.072 DBMET01269 | ||
| 0.261 | 0.028 | 0.265 | Insulin sensitizer | 0.265 0.027 DBMET01269 | DBMET01269 | |
| 0.295 | 0.071 | 0.295 | 5 Hydroxytryptamine release stimulant | 0.204 0.118 DBMET01269 | ||
| 0.224 | 0.014 | 0.245 | Cathepsin G inhibitor | 0.245 0.013 DBMET01269 | DBMET01269 | |
| 0.21 | 0.003 | 0.226 | Prolyl endopeptidase inhibitor | 0.226 0.002 DBMET01269 | DBMET01269 | |
| 0.203 | 0.003 | 0.329 | Angiotensin-converting enzyme 2 inhibitor | 0.329 0.002 DBMET01269 | DBMET01269 | |
| 0.218 | 0.02 | 0.277 | Cell adhesion inhibitor | 0.277 0.012 DBMET01269 | DBMET01269 | |
| 0.216 | 0.019 | 0.301 | Cathepsin H inhibitor | 0.301 0.01 DBMET01269 | DBMET01269 | |
| 0.264 | 0.073 | 0.264 | Transcription factor STAT3 inhibitor | 0.253 0.081 DBMET01269 | ||
| 0.234 | 0.048 | 0.319 | Growth hormone agonist | 0.319 0.029 DBMET01269 | DBMET01269 | |
| 0.191 | 0.008 | 0.307 | Aminopeptidase I inhibitor | 0.307 0.003 DBMET01269 | DBMET01269 | |
| 0.261 | 0.079 | 0.261 | Transcription factor STAT inhibitor | 0.257 0.082 DBMET01269 | ||
| 0.274 | 0.097 | 0.302 | Immunomodulator | 0.302 0.081 DBMET01269 | DBMET01269 | |
| 0.197 | 0.026 | 0.197 | Proteasome inhibitor | 0.18 0.032 DBMET01269 | ||
| 0.19 | 0.021 | 0.226 | Falcipain 3 inhibitor | 0.226 0.011 DBMET01269 | DBMET01269 | |
| 0.276 | 0.109 | 0.276 | Transcription factor NF kappa B inhibitor | 0.243 0.133 DBMET01269 | ||
| 0.198 | 0.033 | 0.198 | Anesthetic local | |||
| 0.234 | 0.08 | 0.234 | Calpain inhibitor | 0.194 0.119 DBMET01269 | ||
| 0.28 | 0.128 | 0.28 | Immunosuppressant | 0.276 0.13 DBMET01269 | ||
| 0.165 | 0.017 | 0.211 | Folate antagonist | 0.211 0.008 DBMET01269 | DBMET01269 | |
| 0.262 | 0.116 | 0.274 | Apoptosis antagonist | 0.274 0.105 DBMET01269 | DBMET01269 | |
| 0.166 | 0.025 | 0.179 | Falcipain inhibitor | 0.179 0.02 DBMET01269 | DBMET01269 | |
| 0.153 | 0.015 | 0.153 | Acetylcholine release stimulant | 0.109 0.067 DBMET01269 | ||
| 0.153 | 0.014 | 0.213 | Cell adhesion molecule inhibitor | 0.213 0.009 DBMET01269 | DBMET01269 | |
| 0.161 | 0.024 | 0.175 | Falcipain 2 inhibitor | 0.175 0.02 DBMET01269 | DBMET01269 | |
| 0.138 | 0.008 | 0.138 | Elastase 1 inhibitor | 0.123 0.011 DBMET01269 | ||
| 0.147 | 0.018 | 0.155 | Interleukin 1 beta converting enzyme inhibitor | 0.155 0.015 DBMET01269 | DBMET01269 | |
| 0.174 | 0.053 | 0.194 | Insulin secretagoues | 0.194 0.039 DBMET01269 | DBMET01269 | |
| 0.189 | 0.072 | 0.189 | P-glycoprotein inhibitor | 0.165 0.096 DBMET01269 | ||
| 0.135 | 0.02 | 0.135 | Chymotrypsin inhibitor | 0.133 0.021 DBMET01269 | ||
| 0.143 | 0.033 | 0.152 | Caspase 3 inhibitor | 0.152 0.027 DBMET01269 | DBMET01269 | |
| 0.162 | 0.055 | 0.183 | Hemostatic | 0.183 0.04 DBMET01269 | DBMET01269 | |
| 0.11 | 0.005 | 0.132 | Leukotriene A4 hydrolase inhibitor | 0.132 0.005 DBMET01269 | DBMET01269 | |
| 0.158 | 0.053 | 0.158 | Neuropeptide Y1 antagonist | 0.147 0.069 DBMET01269 | ||
| 0.135 | 0.038 | 0.135 | Protease inhibitor | 0.133 0.039 DBMET01269 | ||
| 0.153 | 0.057 | 0.165 | Bone formation stimulant | 0.165 0.049 DBMET01269 | DBMET01269 | |
| 0.107 | 0.013 | 0.107 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.033 DBMET01269 | ||
| 0.121 | 0.029 | 0.178 | Metalloproteinase-2 inhibitor | 0.178 0.013 DBMET01269 | DBMET01269 | |
| 0.097 | 0.009 | 0.229 | CD45 antagonist | 0.229 0.004 DBMET01269 | DBMET01269 | |
| 0.137 | 0.054 | 0.137 | Vanilloid 1 agonist | 0.124 0.078 DBMET01269 | ||
| 0.106 | 0.023 | 0.115 | Thrombin inhibitor | 0.115 0.019 DBMET01269 | DBMET01269 | |
| 0.094 | 0.011 | 0.094 | Elastase inhibitor | 0.092 0.012 DBMET01269 | ||
| 0.094 | 0.015 | 0.182 | Neurotensin receptor antagonist | 0.182 0.008 DBMET01269 | DBMET01269 | |
| 0.106 | 0.028 | 0.124 | Analgesic, opioid | 0.124 0.021 DBMET01269 | DBMET01269 | |
| 0.106 | 0.032 | 0.123 | Factor XII inhibitor | 0.123 0.022 DBMET01269 | DBMET01269 | |
| 0.085 | 0.012 | 0.135 | Dipeptidyl peptidase inhibitor | 0.135 0.005 DBMET01269 | DBMET01269 | |
| 0.084 | 0.011 | 0.099 | Calcitonin receptor agonist | 0.099 0.009 DBMET01269 | DBMET01269 | |
| 0.104 | 0.032 | 0.125 | Hematopoietic | 0.125 0.02 DBMET01269 | DBMET01269 | |
| 0.075 | 0.005 | 0.12 | Neutral endopeptidase inhibitor | 0.12 0.004 DBMET01269 | DBMET01269 | |
| 0.088 | 0.018 | 0.098 | Cathepsin E inhibitor | 0.098 0.014 DBMET01269 | DBMET01269 | |
| 0.099 | 0.03 | 0.147 | Opioid delta receptor antagonist | 0.147 0.02 DBMET01269 | DBMET01269 | |
| 0.089 | 0.021 | 0.089 | Beta adrenoreceptor antagonist | 0.068 0.041 DBMET01269 | ||
| 0.161 | 0.094 | 0.176 | Platelet adhesion inhibitor | 0.176 0.085 DBMET01269 | DBMET01269 | |
| 0.108 | 0.042 | 0.146 | Opioid antagonist | 0.146 0.027 DBMET01269 | DBMET01269 | |
| 0.07 | 0.005 | 0.21 | Lysine carboxypeptidase inhibitor | 0.21 0.002 DBMET01269 | DBMET01269 | |
| 0.194 | 0.13 | 0.22 | Neuropeptide Y2 antagonist | 0.22 0.089 DBMET01269 | DBMET01269 | |
| 0.135 | 0.072 | 0.135 | Calcium channel blocker | |||
| 0.131 | 0.068 | 0.208 | Alpha-N-acetylglucosaminidase inhibitor | 0.208 0.032 DBMET01269 | DBMET01269 | |
| 0.086 | 0.023 | 0.132 | Ribonucleoside-diphosphate reductase inhibitor | 0.132 0.014 DBMET01269 | DBMET01269 | |
| 0.118 | 0.056 | 0.118 | Mucolytic | 0.108 0.067 DBMET01269 | ||
| 0.085 | 0.025 | 0.127 | Ribonucleotide reductase inhibitor | 0.127 0.016 DBMET01269 | DBMET01269 | |
| 0.08 | 0.022 | 0.08 | Nitric oxide donor | 0.065 0.04 DBMET01269 | ||
| 0.189 | 0.13 | 0.289 | Superoxide dismutase inhibitor | 0.289 0.054 DBMET01269 | DBMET01269 | |
| 0.11 | 0.051 | 0.113 | Factor V inhibitor | 0.113 0.047 DBMET01269 | DBMET01269 | |
| 0.088 | 0.032 | 0.12 | Matrix metalloproteinase inhibitor | 0.12 0.02 DBMET01269 | DBMET01269 | |
| 0.066 | 0.011 | 0.113 | Dipeptidyl peptidase IV inhibitor | 0.113 0.005 DBMET01269 | DBMET01269 | |
| 0.133 | 0.077 | 0.165 | Histone deacetylase SIRT1 inhibitor | 0.165 0.05 DBMET01269 | DBMET01269 | |
| 0.157 | 0.103 | 0.157 | Hepatoprotectant | 0.142 0.118 DBMET01269 | ||
| 0.079 | 0.027 | 0.088 | Trypsin inhibitor | 0.088 0.023 DBMET01269 | DBMET01269 | |
| 0.077 | 0.025 | 0.084 | Caspase 9 inhibitor | 0.084 0.021 DBMET01269 | DBMET01269 | |
| 0.057 | 0.006 | 0.075 | Glutamate (mGluR8) antagonist | 0.075 0.004 DBMET01269 | DBMET01269 | |
| 0.075 | 0.026 | 0.075 | Human rhinovirus A protease inhibitor | 0.07 0.028 DBMET01269 | ||
| 0.054 | 0.005 | 0.062 | Angiotensin II receptor antagonist | 0.062 0.004 DBMET01269 | DBMET01269 | |
| 0.059 | 0.011 | 0.09 | Arginase inhibitor | 0.09 0.004 DBMET01269 | DBMET01269 | |
| 0.071 | 0.024 | 0.098 | Matrix metalloproteinase (membrane-type) inhibitor | 0.098 0.015 DBMET01269 | DBMET01269 | |
| 0.089 | 0.042 | 0.103 | Somatostatin 1 agonist | 0.103 0.032 DBMET01269 | DBMET01269 | |
| 0.084 | 0.038 | 0.119 | Opioid mu receptor antagonist | 0.119 0.025 DBMET01269 | DBMET01269 | |
| 0.074 | 0.028 | 0.074 | Cathepsin L inhibitor | 0.07 0.03 DBMET01269 | ||
| 0.112 | 0.067 | 0.112 | Calcium channel (voltage-sensitive) blocker | |||
| 0.064 | 0.018 | 0.088 | HCV NS3/NS4A protease inhibitor | 0.088 0.008 DBMET01269 | DBMET01269 | |
| 0.08 | 0.035 | 0.102 | Glucagon-like peptide 1 agonist | 0.102 0.021 DBMET01269 | DBMET01269 | |
| 0.049 | 0.005 | 0.056 | Tryptophan 5 hydroxylase inhibitor | 0.056 0.004 DBMET01269 | DBMET01269 | |
| 0.054 | 0.011 | 0.058 | Baculoviral IAP repeat-containing protein inhibitor | 0.058 0.006 DBMET01269 | DBMET01269 | |
| 0.052 | 0.009 | 0.067 | Angiotensin AT2 receptor antagonist | 0.067 0.007 DBMET01269 | DBMET01269 | |
| 0.064 | 0.022 | 0.085 | Metalloproteinase-3 inhibitor | 0.085 0.014 DBMET01269 | DBMET01269 | |
| 0.053 | 0.014 | 0.057 | Angiotensin AT1 receptor antagonist | 0.057 0.009 DBMET01269 | DBMET01269 | |
| 0.112 | 0.074 | 0.112 | Calcium channel N-type blocker | |||
| 0.044 | 0.006 | 0.1 | LFA antagonist | 0.1 0.004 DBMET01269 | DBMET01269 | |
| 0.067 | 0.03 | 0.075 | Prolactin release inhibitor | 0.075 0.015 DBMET01269 | DBMET01269 | |
| 0.064 | 0.027 | 0.14 | NMDA 2A receptor antagonist | 0.14 0.008 DBMET01269 | DBMET01269 | |
| 0.068 | 0.033 | 0.081 | Plasminogen activator inhibitor | 0.081 0.025 DBMET01269 | DBMET01269 | |
| 0.061 | 0.027 | 0.103 | GP IIb/IIIa receptor antagonist | 0.103 0.017 DBMET01269 | DBMET01269 | |
| 0.068 | 0.035 | 0.069 | Neuraminidase inhibitor | 0.069 0.034 DBMET01269 | DBMET01269 | |
| 0.131 | 0.098 | 0.131 | Phospholipase A2 inhibitor | |||
| 0.123 | 0.09 | 0.132 | Protein kinase stimulant | 0.132 0.082 DBMET01269 | DBMET01269 | |
| 0.082 | 0.049 | 0.084 | Interferon agonist | 0.084 0.045 DBMET01269 | DBMET01269 | |
| 0.045 | 0.013 | 0.066 | Caspase 2 inhibitor | 0.066 0.008 DBMET01269 | DBMET01269 | |
| 0.037 | 0.006 | 0.089 | Integrin alpha4beta1 antagonist | 0.089 0.004 DBMET01269 | DBMET01269 | |
| 0.065 | 0.036 | 0.078 | Aminopeptidase microsomal inhibitor | 0.078 0.026 DBMET01269 | DBMET01269 | |
| 0.035 | 0.009 | 0.054 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.054 0.004 DBMET01269 | DBMET01269 | |
| 0.061 | 0.035 | 0.064 | Cathepsin B inhibitor | 0.064 0.032 DBMET01269 | DBMET01269 | |
| 0.039 | 0.014 | 0.039 | Trypsin II inhibitor | 0.03 0.02 DBMET01269 | ||
| 0.029 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.03 0.005 DBMET01269 | DBMET01269 | |
| 0.065 | 0.041 | 0.139 | NMDA receptor agonist | 0.139 0.01 DBMET01269 | DBMET01269 | |
| 0.042 | 0.018 | 0.051 | Integrin alpha1beta1 antagonist | 0.051 0.007 DBMET01269 | DBMET01269 | |
| 0.032 | 0.009 | 0.036 | Aminopeptidase P inhibitor | 0.036 0.007 DBMET01269 | DBMET01269 | |
| 0.047 | 0.025 | 0.047 | Beta adrenoreceptor agonist | 0.044 0.035 DBMET01269 | ||
| 0.197 | 0.175 | 0.205 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.205 0.152 DBMET01269 | DBMET01269 | |
| 0.049 | 0.028 | 0.163 | Integrin antagonist | 0.163 0.009 DBMET01269 | DBMET01269 | |
| 0.051 | 0.031 | 0.063 | Plasmin inhibitor | 0.063 0.027 DBMET01269 | DBMET01269 | |
| 0.064 | 0.044 | 0.064 | Neuraminidase (influenza) inhibitor | 0.062 0.05 DBMET01269 | ||
| 0.05 | 0.032 | 0.059 | Collagenase inhibitor | 0.059 0.017 DBMET01269 | DBMET01269 | |
| 0.087 | 0.07 | 0.217 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.217 0.013 DBMET01269 | DBMET01269 | |
| 0.039 | 0.022 | 0.039 | Integrin alpha2 antagonist | 0.038 0.023 DBMET01269 | ||
| 0.142 | 0.126 | 0.142 | Catenin beta inhibitor | |||
| 0.061 | 0.044 | 0.095 | NMDA 2C receptor antagonist | 0.095 0.017 DBMET01269 | DBMET01269 | |
| 0.069 | 0.053 | 0.069 | Calcium channel L-type blocker | |||
| 0.093 | 0.078 | 0.093 | Expectorant | |||
| 0.023 | 0.008 | 0.025 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.025 0.006 DBMET01269 | DBMET01269 | |
| 0.045 | 0.03 | 0.045 | Dihydroorotase inhibitor | |||
| 0.03 | 0.016 | 0.032 | HCV NS5A inhibitor | 0.032 0.011 DBMET01269 | DBMET01269 | |
| 0.028 | 0.015 | 0.028 | Integrin alpha2beta1 antagonist | 0.026 0.018 DBMET01269 | ||
| 0.049 | 0.035 | 0.057 | Bombesin 2 receptor antagonist | 0.057 0.026 DBMET01269 | DBMET01269 | |
| 0.031 | 0.018 | 0.038 | Bradykinin B2 receptor agonist | 0.038 0.013 DBMET01269 | DBMET01269 | |
| 0.125 | 0.113 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | 0.147 0.066 DBMET01269 | DBMET01269 | |
| 0.108 | 0.098 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | 0.106 0.103 DBMET01269 | ||
| 0.05 | 0.039 | 0.081 | Matrix metalloproteinase 1 inhibitor | 0.081 0.021 DBMET01269 | DBMET01269 | |
| 0.044 | 0.034 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 DBMET01269 | DBMET01269 | |
| 0.075 | 0.066 | 0.091 | Opioid kappa receptor antagonist | 0.091 0.044 DBMET01269 | DBMET01269 | |
| 0.015 | 0.006 | 0.04 | Integrin beta2 antagonist | 0.04 0.004 DBMET01269 | DBMET01269 | |
| 0.032 | 0.023 | 0.041 | Trypsin I inhibitor | 0.041 0.016 DBMET01269 | DBMET01269 | |
| 0.019 | 0.011 | 0.052 | Aminopeptidase A inhibitor | 0.052 0.003 DBMET01269 | DBMET01269 | |
| 0.078 | 0.07 | 0.078 | Ornithine decarboxylase inhibitor | |||
| 0.059 | 0.052 | 0.103 | Neutrophil collagenase inhibitor | 0.103 0.021 DBMET01269 | DBMET01269 | |
| 0.044 | 0.037 | 0.056 | Aminopeptidase N inhibitor | 0.056 0.027 DBMET01269 | DBMET01269 | |
| 0.022 | 0.015 | 0.022 | Elastase 2A inhibitor | |||
| 0.022 | 0.015 | 0.022 | Elastase 2 inhibitor | |||
| 0.077 | 0.07 | 0.128 | NMDA receptor antagonist | 0.128 0.032 DBMET01269 | DBMET01269 | |
| 0.063 | 0.057 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET01269 | DBMET01269 | |
| 0.017 | 0.011 | 0.021 | Tryptophan hydroxylase 1 inhibitor | 0.021 0.005 DBMET01269 | DBMET01269 | |
| 0.041 | 0.035 | 0.076 | Nicotinic receptor alpha3 subunit antagonist | 0.076 0.014 DBMET01269 | DBMET01269 | |
| 0.067 | 0.061 | 0.076 | Glutamate dehydrogenase inhibitor | 0.076 0.049 DBMET01269 | DBMET01269 | |
| 0.023 | 0.019 | 0.097 | Integrin alpha4 antagonist | 0.097 0.006 DBMET01269 | DBMET01269 | |
| 0.034 | 0.03 | 0.035 | Tryptase inhibitor | 0.035 0.028 DBMET01269 | DBMET01269 | |
| 0.041 | 0.036 | 0.049 | Glutamate (mGluR4) antagonist | 0.049 0.022 DBMET01269 | DBMET01269 | |
| 0.048 | 0.044 | 0.055 | Neuropeptide agonist | 0.055 0.04 DBMET01269 | DBMET01269 | |
| 0.015 | 0.011 | 0.017 | CC chemokine 10 receptor antagonist | 0.017 0.007 DBMET01269 | DBMET01269 | |
| 0.037 | 0.033 | 0.054 | Integrin alpha5beta1 antagonist | 0.054 0.015 DBMET01269 | DBMET01269 | |
| 0.149 | 0.146 | 0.149 | Free radical scavenger | |||
| 0.033 | 0.03 | 0.033 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.025 | 0.022 | 0.033 | NMDA 2D receptor antagonist | 0.033 0.013 DBMET01269 | DBMET01269 | |
| 0.029 | 0.027 | 0.033 | Growth hormone releasing factor agonist | 0.033 0.023 DBMET01269 | DBMET01269 | |
| 0.014 | 0.012 | 0.017 | Dipeptidyl peptidase VIII inhibitor | 0.017 0.009 DBMET01269 | DBMET01269 | |
| 0.078 | 0.076 | 0.078 | Vanilloid agonist | |||
| 0.04 | 0.038 | 0.061 | Endothelin-converting enzyme inhibitor | 0.061 0.024 DBMET01269 | DBMET01269 | |
| 0.102 | 0.101 | 0.102 | Toll-Like receptor 2 antagonist | |||
| 0.014 | 0.013 | 0.018 | Dipeptidyl peptidase IX inhibitor | 0.018 0.009 DBMET01269 | DBMET01269 | |
| 0.04 | 0.041 | 0.048 | Opioid mu receptor agonist | 0.048 0.031 DBMET01269 | DBMET01269 | |
| 0.031 | 0.033 | 0.038 | HCV polyprotein inhibitor | 0.038 0.015 DBMET01269 | DBMET01269 | |
| 0.194 | 0.196 | 0.262 | Sodium/bile acid cotransporter inhibitor | 0.262 0.116 DBMET01269 | DBMET01269 | |
| 0.113 | 0.116 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.085 DBMET01269 | DBMET01269 | |
| 0.028 | 0.032 | 0.048 | Dipeptidyl peptidase II inhibitor | 0.048 0.01 DBMET01269 | DBMET01269 | |
| 0.04 | 0.044 | 0.046 | Melanocortin antagonist | 0.046 0.034 DBMET01269 | DBMET01269 | |
| 0.017 | 0.021 | 0.021 | Caspase 8 inhibitor | 0.021 0.011 DBMET01269 | DBMET01269 | |
| 0.034 | 0.039 | 0.042 | Melanocortin 4 antagonist | 0.042 0.029 DBMET01269 | DBMET01269 | |
| 0.03 | 0.035 | 0.056 | Cholecystokinin antagonist | 0.056 0.022 DBMET01269 | DBMET01269 | |
| 0.043 | 0.049 | 0.055 | Opioid agonist | 0.055 0.035 DBMET01269 | DBMET01269 | |
| 0.031 | 0.037 | 0.038 | Cholecystokinin B agonist | 0.038 0.025 DBMET01269 | DBMET01269 | |
| 0.032 | 0.039 | 0.066 | Complement C3a chemotactic receptor antagonist | 0.066 0.019 DBMET01269 | DBMET01269 | |
| 0.088 | 0.096 | 0.098 | Chelator | 0.098 0.08 DBMET01269 | DBMET01269 | |
| 0.029 | 0.038 | 0.037 | Melanocortin 1 antagonist | 0.037 0.027 DBMET01269 | DBMET01269 | |
| 0.034 | 0.044 | 0.044 | Sphingosine 1-phosphate receptor 1 agonist | 0.044 0.026 DBMET01269 | DBMET01269 | |
| 0.033 | 0.045 | 0.04 | Opioid kappa receptor agonist | 0.04 0.034 DBMET01269 | DBMET01269 | |
| 0.164 | 0.177 | 0.18 | DNA synthesis inhibitor | 0.18 0.154 DBMET01269 | DBMET01269 | |
| 0.028 | 0.041 | 0.032 | Opioid delta receptor agonist | 0.032 0.031 DBMET01269 | DBMET01269 | |
| 0.029 | 0.042 | 0.081 | Kainate receptor antagonist | 0.081 0.01 DBMET01269 | DBMET01269 | |
| 0.02 | 0.034 | 0.031 | Cholecystokinin B antagonist | 0.031 0.021 DBMET01269 | DBMET01269 | |
| 0.009 | 0.025 | 0.014 | Integrin alphaLbeta2 antagonist | 0.014 0.008 DBMET01269 | DBMET01269 | |
| 0.047 | 0.064 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.035 DBMET01269 | DBMET01269 | |
| 0.024 | 0.04 | 0.037 | Cholecystokinin A antagonist | 0.037 0.026 DBMET01269 | DBMET01269 | |
| 0.027 | 0.044 | 0.034 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 DBMET01269 | DBMET01269 | |
| 0.131 | 0.151 | 0.158 | Phospholipase C inhibitor | 0.158 0.09 DBMET01269 | DBMET01269 | |
| 0.022 | 0.042 | 0.081 | Kainate receptor 2 antagonist | 0.081 0.006 DBMET01269 | DBMET01269 | |
| 0.116 | 0.136 | 0.126 | Adenylate cyclase stimulant | 0.126 0.111 DBMET01269 | DBMET01269 | |
| 0.011 | 0.031 | 0.023 | Integrin alpha4beta7 antagonist | 0.023 0.012 DBMET01269 | DBMET01269 | |
| 0.012 | 0.034 | 0.077 | VLA-4 antagonist | 0.077 0.008 DBMET01269 | DBMET01269 | |
| 0.014 | 0.039 | 0.031 | Bradykinin B2 receptor antagonist | 0.031 0.022 DBMET01269 | DBMET01269 | |
| 0.059 | 0.083 | 0.091 | Metalloproteinase-9 inhibitor | 0.091 0.037 DBMET01269 | DBMET01269 | |
| 0.005 | 0.03 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.01 DBMET01269 | DBMET01269 | |
| 0.032 | 0.056 | 0.043 | Sphingosine 1-phosphate receptor agonist | 0.043 0.033 DBMET01269 | DBMET01269 | |
| 0.035 | 0.059 | 0.041 | Farnesyltransferase inhibitor | 0.041 0.04 DBMET01269 | DBMET01269 | |
| 0.035 | 0.06 | 0.042 | Glutamate (mGluR group III) antagonist | 0.042 0.035 DBMET01269 | DBMET01269 | |
| 0.106 | 0.132 | 0.129 | Protein-tyrosine phosphatase inhibitor | 0.129 0.103 DBMET01269 | DBMET01269 | |
| 0.017 | 0.043 | 0.029 | ICAM 1 antagonist | 0.029 0.008 DBMET01269 | DBMET01269 | |
| 0.204 | 0.232 | 0.232 | Analgesic | 0.232 0.2 DBMET01269 | DBMET01269 | |
| 0.019 | 0.047 | 0.035 | Peptide deformylase inhibitor | 0.035 0.017 DBMET01269 | DBMET01269 | |
| 0.116 | 0.145 | 0.144 | Interferon gamma antagonist | 0.144 0.086 DBMET01269 | DBMET01269 | |
| 0.023 | 0.052 | 0.057 | NMDA receptor subunit 3A antagonist | 0.057 0.017 DBMET01269 | DBMET01269 | |
| 0.008 | 0.038 | 0.05 | Kainate receptor 1 antagonist | 0.05 0.005 DBMET01269 | DBMET01269 | |
| 0.024 | 0.057 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.021 DBMET01269 | DBMET01269 | |
| 0.116 | 0.151 | 0.169 | DNA methyltransferase I inhibitor | 0.169 0.087 DBMET01269 | DBMET01269 | |
| 0.014 | 0.05 | 0.038 | AMPA 2 receptor antagonist | 0.038 0.015 DBMET01269 | DBMET01269 | |
| 0.041 | 0.077 | 0.077 | Carbonic anhydrase stimulant | 0.077 0.027 DBMET01269 | DBMET01269 | |
| 0.021 | 0.057 | 0.034 | Bradykinin antagonist | 0.034 0.03 DBMET01269 | DBMET01269 | |
| 0.025 | 0.062 | 0.04 | Erythropoietin receptor agonist | 0.04 0.029 DBMET01269 | DBMET01269 | |
| 0.014 | 0.052 | 0.058 | AMPA 3 receptor antagonist | 0.058 0.006 DBMET01269 | DBMET01269 | |
| 0.123 | 0.163 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.089 DBMET01269 | DBMET01269 | |
| 0.008 | 0.05 | 0.019 | Integrin beta7 antagonist | 0.019 0.014 DBMET01269 | DBMET01269 | |
| 0.092 | 0.136 | 0.109 | Transcription factor STAT6 inhibitor | 0.109 0.082 DBMET01269 | DBMET01269 | |
| 0.047 | 0.092 | 0.06 | Sirtuin 1 inhibitor | 0.06 0.058 DBMET01269 | DBMET01269 | |
| 0.037 | 0.085 | 0.049 | Carbonic anhydrase II stimulant | 0.049 0.042 DBMET01269 | DBMET01269 | |
| 0.016 | 0.065 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET01269 | DBMET01269 | |
| 0.171 | 0.221 | 0.252 | 5 Hydroxytryptamine uptake stimulant | 0.252 0.079 DBMET01269 | DBMET01269 | |
| 0.022 | 0.074 | 0.056 | Glutamate (mGluR3) antagonist | 0.056 0.01 DBMET01269 | DBMET01269 | |
| 0.03 | 0.084 | 0.055 | Kainate receptor agonist | 0.055 0.009 DBMET01269 | DBMET01269 | |
| 0.112 | 0.167 | 0.189 | DNA methylase inhibitor | 0.189 0.087 DBMET01269 | DBMET01269 | |
| 0.007 | 0.061 | 0.036 | AMPA 1 receptor antagonist | 0.036 0.017 DBMET01269 | DBMET01269 | |
| 0.022 | 0.083 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 DBMET01269 | DBMET01269 | |
| 0.176 | 0.238 | 0.223 | Antiobesity | 0.223 0.183 DBMET01269 | DBMET01269 | |
| 0.02 | 0.087 | 0.038 | Macrophage elastase inhibitor | 0.038 0.036 DBMET01269 | DBMET01269 | |
| 0.12 | 0.189 | 0.161 | Antiamyloidogenic | 0.161 0.132 DBMET01269 | DBMET01269 | |
| 0.029 | 0.101 | 0.037 | VCAM-1 antagonist | 0.037 0.036 DBMET01269 | DBMET01269 | |
| 0.029 | 0.101 | 0.037 | VCAM antagonist | 0.037 0.036 DBMET01269 | DBMET01269 | |
| 0.035 | 0.119 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.053 DBMET01269 | DBMET01269 | |
| 0.02 | 0.104 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.034 DBMET01269 | DBMET01269 | |
| 0.027 | 0.116 | 0.055 | NMDA receptor glycine site agonist | 0.055 0.051 DBMET01269 | DBMET01269 | |
| 0.02 | 0.119 | 0.059 | NMDA receptor subunit 3B antagonist | 0.059 0.02 DBMET01269 | DBMET01269 | |
| 0.021 | 0.153 | 0.056 | Argininosuccinate synthase inhibitor | 0.056 0.04 DBMET01269 | DBMET01269 | |
| 0.02 | 0.153 | 0.071 | NMDA 2 receptor antagonist | 0.071 0.05 DBMET01269 | DBMET01269 | |
| 0.062 | 0.201 | 0.1 | Glutamate (mGluR7) agonist | 0.1 0.06 DBMET01269 | DBMET01269 | |
| 0.029 | 0.176 | 0.073 | Glutamate decarboxylase inhibitor | 0.073 0.051 DBMET01269 | DBMET01269 | |
| 0.016 | 0.183 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.02 DBMET01269 | DBMET01269 | |
| 0.044 | 0.211 | 0.107 | GABA C receptor agonist | 0.107 0.06 DBMET01269 | DBMET01269 | |
| 0.053 | 0.262 | 0.098 | DOPA decarboxylase inhibitor | 0.098 0.08 DBMET01269 | DBMET01269 | |
| 0.014 | 0.281 | 0.068 | Glutamate receptor agonist | 0.068 0.066 DBMET01269 | DBMET01269 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |